Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   



Processing
Collecting data for BPTH and ALKS ...

Asset Comparison and Correlation

    
       
Investment horizon: 
30 Days (Login to change)
       
 
    
 Biopath Holdings Inc  and   Alkermes Inc.
Check Correlation Matrix  
Daily Returns (%)
BPTH  ALKS  
Timeline
Assuming 30 trading days horizon, Biopath Holdings Inc is expected to generate 3.36 times more return on investment than Alkermes. However, Biopath is 3.36 times more volatile than Alkermes Inc.. It trades about 0.16 of its potential returns per unit of risk. Alkermes Inc. is currently generating about -0.2 per unit of risk. If you would invest 27.00 in Biopath Holdings Inc on April 25, 2012 and sell it today you would earn a total of 7.00 from holding Biopath Holdings Inc or generate 25.93% return on investment over 30 days.

Diversification

Significant diversification
Overlapping area represents amount of risk that can be diversified away by holding Biopath Holdings Inc and Alkermes Inc. in the same portfolio (assuming nothing else is changed)

Correlation Coefficient

0.07
 Parameters
Time Period1 Month [change]
DirectionPositive ALKS Moved Up vs BPTH.OB
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns
    
Follow Correlation between BPTH and ALKS with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Correlation between BPTH and ALKS to your reader
 
Get social with Correlation between BPTH and ALKS
 Share Correlation between BPTH and ALKS 
Share Share Correlation between BPTH and ALKS
    
    
 
       
Predicted Return Density
Expected Daily Returns   
BPTH  ALKS  

Biopath Holdings Inc

 
    
    
Biopath
Performance
6
Out Of
100
Over 30
Days
94% of all equities and portfolios perform better than Biopath Holdings Inc. Compared with the overall equity markets, risk-adjusted returns on investments in Biopath Holdings Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 30 days.
    
    
Valeant Pharmaceuticals International Inc. vs. Biopath Holdings Inc
Elan Corporation plc vs. Biopath Holdings Inc
Hospira Inc. vs. Biopath Holdings Inc
Alkermes Inc. vs. Biopath Holdings Inc
PetMed Express Inc. vs. Biopath Holdings Inc
Acura Pharmaceuticals Inc. vs. Biopath Holdings Inc
  

Alkermes Inc.

 
    
    
Alkermes
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Alkermes Inc. has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
Valeant Pharmaceuticals International Inc. vs. Alkermes Inc.
Elan Corporation plc vs. Alkermes Inc.
Hospira Inc. vs. Alkermes Inc.
PetMed Express Inc. vs. Alkermes Inc.
Acura Pharmaceuticals Inc. vs. Alkermes Inc.
Flamel Technologies SA vs. Alkermes Inc.
       


 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting